| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | copper ion binding | 1.23e-06 | 78 | 21 | 4 | GO:0005507 | |
| GeneOntologyMolecularFunction | cadmium ion binding | 6.91e-05 | 12 | 21 | 2 | GO:0046870 | |
| GeneOntologyMolecularFunction | zinc ion binding | 1.96e-03 | 891 | 21 | 5 | GO:0008270 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 6.78e-03 | 1189 | 21 | 5 | GO:0046914 | |
| GeneOntologyBiologicalProcess | detoxification of copper ion | 1.20e-12 | 16 | 18 | 5 | GO:0010273 | |
| GeneOntologyBiologicalProcess | stress response to copper ion | 1.20e-12 | 16 | 18 | 5 | GO:1990169 | |
| GeneOntologyBiologicalProcess | stress response to metal ion | 7.19e-12 | 22 | 18 | 5 | GO:0097501 | |
| GeneOntologyBiologicalProcess | detoxification of inorganic compound | 1.45e-11 | 25 | 18 | 5 | GO:0061687 | |
| GeneOntologyBiologicalProcess | cellular response to copper ion | 2.20e-11 | 27 | 18 | 5 | GO:0071280 | |
| GeneOntologyBiologicalProcess | cellular response to zinc ion | 2.68e-11 | 28 | 18 | 5 | GO:0071294 | |
| GeneOntologyBiologicalProcess | cellular response to chromate | 2.84e-11 | 8 | 18 | 4 | GO:0071247 | |
| GeneOntologyBiologicalProcess | response to chromate | 5.10e-11 | 9 | 18 | 4 | GO:0046687 | |
| GeneOntologyBiologicalProcess | keratinization | 8.42e-11 | 87 | 18 | 6 | GO:0031424 | |
| GeneOntologyBiologicalProcess | cellular response to cadmium ion | 2.60e-10 | 43 | 18 | 5 | GO:0071276 | |
| GeneOntologyBiologicalProcess | response to copper ion | 2.60e-10 | 43 | 18 | 5 | GO:0046688 | |
| GeneOntologyBiologicalProcess | intracellular zinc ion homeostasis | 2.93e-10 | 44 | 18 | 5 | GO:0006882 | |
| GeneOntologyBiologicalProcess | response to zinc ion | 1.59e-09 | 61 | 18 | 5 | GO:0010043 | |
| GeneOntologyBiologicalProcess | response to cadmium ion | 2.78e-09 | 68 | 18 | 5 | GO:0046686 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 9.26e-09 | 189 | 18 | 6 | GO:0030216 | |
| GeneOntologyBiologicalProcess | cellular response to metal ion | 2.23e-08 | 219 | 18 | 6 | GO:0071248 | |
| GeneOntologyBiologicalProcess | nitric oxide mediated signal transduction | 3.64e-08 | 40 | 18 | 4 | GO:0007263 | |
| GeneOntologyBiologicalProcess | epidermis development | 6.85e-08 | 461 | 18 | 7 | GO:0008544 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.04e-07 | 284 | 18 | 6 | GO:0009913 | |
| GeneOntologyBiologicalProcess | detoxification | 2.82e-07 | 170 | 18 | 5 | GO:0098754 | |
| GeneOntologyBiologicalProcess | skin development | 5.19e-07 | 373 | 18 | 6 | GO:0043588 | |
| GeneOntologyBiologicalProcess | response to metal ion | 9.68e-07 | 415 | 18 | 6 | GO:0010038 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | 3.47e-06 | 283 | 18 | 5 | GO:0045926 | |
| GeneOntologyBiologicalProcess | response to toxic substance | 3.85e-06 | 289 | 18 | 5 | GO:0009636 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron apoptotic process | 4.51e-05 | 236 | 18 | 4 | GO:0043524 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | 6.64e-05 | 870 | 18 | 6 | GO:0030855 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 1.40e-04 | 611 | 18 | 5 | GO:0030003 | |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | 1.52e-04 | 622 | 18 | 5 | GO:0098771 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 1.52e-04 | 622 | 18 | 5 | GO:0006873 | |
| GeneOntologyBiologicalProcess | regulation of neuron apoptotic process | 2.18e-04 | 355 | 18 | 4 | GO:0043523 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | 2.72e-04 | 705 | 18 | 5 | GO:0055080 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | 2.94e-04 | 717 | 18 | 5 | GO:0050801 | |
| GeneOntologyBiologicalProcess | neuron apoptotic process | 3.88e-04 | 413 | 18 | 4 | GO:0051402 | |
| GeneOntologyBiologicalProcess | regulation of growth | 4.26e-04 | 777 | 18 | 5 | GO:0040008 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | 7.00e-04 | 866 | 18 | 5 | GO:0055082 | |
| GeneOntologyBiologicalProcess | epithelium development | 1.14e-03 | 1469 | 18 | 6 | GO:0060429 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | 1.23e-03 | 981 | 18 | 5 | GO:0019725 | |
| GeneOntologyBiologicalProcess | growth | 3.39e-03 | 1235 | 18 | 5 | GO:0040007 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | 3.56e-03 | 1249 | 18 | 5 | GO:0048878 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | 1.49e-02 | 1133 | 18 | 4 | GO:0043066 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | 1.67e-02 | 1171 | 18 | 4 | GO:0043069 | |
| GeneOntologyCellularComponent | intermediate filament | KRTAP5-4 KRTAP5-9 KRTAP9-9 KRTAP1-4 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 3.82e-12 | 227 | 17 | 8 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP5-4 KRTAP5-9 KRTAP9-9 KRTAP1-4 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.24e-11 | 263 | 17 | 8 | GO:0045111 |
| GeneOntologyCellularComponent | keratin filament | 1.15e-08 | 97 | 17 | 5 | GO:0045095 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP5-4 KRTAP5-9 KRTAP9-9 KRTAP1-4 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.95e-07 | 899 | 17 | 8 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRTAP5-4 KRTAP5-9 KRTAP9-9 KRTAP1-4 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.54e-06 | 1179 | 17 | 8 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRTAP5-4 KRTAP5-9 KRTAP9-9 KRTAP1-4 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.62e-06 | 1187 | 17 | 8 | GO:0099081 |
| GeneOntologyCellularComponent | lytic vacuole | 3.57e-03 | 811 | 17 | 4 | GO:0000323 | |
| GeneOntologyCellularComponent | lysosome | 3.57e-03 | 811 | 17 | 4 | GO:0005764 | |
| GeneOntologyCellularComponent | vacuole | 5.45e-03 | 913 | 17 | 4 | GO:0005773 | |
| MousePheno | increased total body fat amount | 2.86e-06 | 424 | 9 | 5 | MP:0010024 | |
| MousePheno | decreased bone mineral content | 4.50e-06 | 465 | 9 | 5 | MP:0010124 | |
| MousePheno | abnormal bone mineral content | 3.61e-05 | 713 | 9 | 5 | MP:0010122 | |
| MousePheno | increased thigmotaxis | 6.63e-05 | 132 | 9 | 3 | MP:0002797 | |
| MousePheno | abnormal adipose tissue amount | 2.61e-04 | 1077 | 9 | 5 | MP:0005452 | |
| MousePheno | abnormal adipose tissue morphology | 7.82e-04 | 1361 | 9 | 5 | MP:0000003 | |
| MousePheno | increased anxiety-related response | 8.29e-04 | 311 | 9 | 3 | MP:0001363 | |
| MousePheno | abnormal bone structure | 8.32e-04 | 1379 | 9 | 5 | MP:0003795 | |
| MousePheno | adipose tissue phenotype | 8.43e-04 | 1383 | 9 | 5 | MP:0005375 | |
| MousePheno | decreased locomotor activity | 1.22e-03 | 829 | 9 | 4 | MP:0001402 | |
| MousePheno | hypoactivity | 2.67e-03 | 1023 | 9 | 4 | MP:0031392 | |
| MousePheno | abnormal anxiety-related response | 9.76e-03 | 740 | 9 | 3 | MP:0001362 | |
| MousePheno | abnormal fear/anxiety-related behavior | 1.76e-02 | 919 | 9 | 3 | MP:0002065 | |
| Domain | Keratin_B2 | KRTAP5-4 KRTAP5-9 KRTAP9-9 KRTAP1-4 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 6.56e-17 | 40 | 22 | 8 | PF01500 |
| Domain | KAP | KRTAP5-4 KRTAP5-9 KRTAP9-9 KRTAP1-4 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.62e-15 | 58 | 22 | 8 | IPR002494 |
| Domain | LCE | 1.55e-14 | 17 | 22 | 6 | PF14672 | |
| Domain | LCE | 1.55e-14 | 17 | 22 | 6 | IPR028205 | |
| Domain | SPRR/LCE | 4.70e-13 | 28 | 22 | 6 | IPR026075 | |
| Domain | METALLOTHIONEIN_VRT | 1.78e-12 | 13 | 22 | 5 | PS00203 | |
| Domain | Metalthion_vert | 2.77e-12 | 14 | 22 | 5 | IPR000006 | |
| Domain | Metalthion | 2.77e-12 | 14 | 22 | 5 | IPR003019 | |
| Domain | Metallothio | 2.77e-12 | 14 | 22 | 5 | PF00131 | |
| Domain | Metalthion_vert_metal_BS | 3.02e-10 | 10 | 22 | 4 | IPR018064 | |
| Domain | Metalthion_dom_vert | 7.10e-10 | 12 | 22 | 4 | IPR023587 | |
| Domain | Metalthion_dom | 7.10e-10 | 12 | 22 | 4 | IPR017854 | |
| Domain | - | 7.10e-10 | 12 | 22 | 4 | 4.10.10.10 | |
| Domain | Keratin_B2_2 | 1.26e-05 | 39 | 22 | 3 | PF13885 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A KRTAP9-9 KRTAP1-4 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 9.83e-22 | 217 | 20 | 14 | M27640 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A KRTAP9-9 KRTAP1-4 LCE1F KRTAP5-11 KRTAP1-5 SLIT1 KRTAP1-1 KRTAP1-3 | 1.12e-11 | 1432 | 20 | 15 | M509 |
| Pathway | REACTOME_METALLOTHIONEINS_BIND_METALS | 9.66e-10 | 11 | 20 | 4 | M27543 | |
| Pathway | WP_ZINC_HOMEOSTASIS | 1.42e-09 | 37 | 20 | 5 | M39377 | |
| Pathway | REACTOME_RESPONSE_TO_METAL_IONS | 2.92e-09 | 14 | 20 | 4 | M27541 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.82e-08 | 129 | 20 | 6 | M27649 | |
| Pathway | WP_OXIDATIVE_STRESS_RESPONSE | 1.69e-07 | 36 | 20 | 4 | MM15941 | |
| Pathway | WP_COPPER_HOMEOSTASIS | 8.25e-07 | 53 | 20 | 4 | M39349 | |
| Pathway | REACTOME_KERATINIZATION | 1.92e-06 | 153 | 20 | 5 | MM15343 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 5.58e-04 | 502 | 20 | 5 | MM14537 | |
| Pathway | WP_VITAMIN_D_RECEPTOR_PATHWAY | 2.15e-03 | 185 | 20 | 3 | M39718 | |
| Pathway | WP_LUNG_FIBROSIS | 4.73e-03 | 73 | 20 | 2 | MM15827 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 2.69e-02 | 828 | 20 | 4 | M27827 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.94e-17 | 630 | 23 | 13 | 36949045 |
| Pubmed | 3.28e-16 | 16 | 23 | 6 | 17410201 | ||
| Pubmed | 3.05e-15 | 22 | 23 | 6 | 15854049 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 4.12e-15 | 23 | 23 | 6 | 11698679 | |
| Pubmed | Human metallothionein genes: structure of the functional locus at 16q13. | 6.27e-14 | 12 | 23 | 5 | 2286373 | |
| Pubmed | Polymorphisms in the human high sulfur hair keratin-associated protein 1, KAP1, gene family. | 1.45e-13 | 4 | 23 | 4 | 12228244 | |
| Pubmed | Localization of metallothionein in the brain of rat and mouse. | 1.02e-11 | 8 | 23 | 4 | 1552172 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 24163136 | ||
| Pubmed | Amplification of the metallothionein-I gene in cadmium-resistant mouse cells. | 1.02e-11 | 8 | 23 | 4 | 6941274 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 27177022 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 17114818 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 14627804 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 15606775 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 22533418 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 19583814 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 10631978 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 16930132 | ||
| Pubmed | Isolation and characterization of the mouse metallothionein-I gene. | 1.02e-11 | 8 | 23 | 4 | 6935664 | |
| Pubmed | Impact of overexpression of metallothionein-1 on cell cycle progression and zinc toxicity. | 1.02e-11 | 8 | 23 | 4 | 18815222 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 11309296 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 22819979 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 15139010 | ||
| Pubmed | Metallothionein-1 suppresses rheumatoid arthritis pathogenesis by shifting the Th17/Treg balance. | 1.02e-11 | 8 | 23 | 4 | 30055006 | |
| Pubmed | The ontogeny of expression of murine metallothionein: comparison with the alpha-fetoprotein gene. | 1.02e-11 | 8 | 23 | 4 | 6202573 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 7925998 | ||
| Pubmed | Paraquat reduces natural killer cell activity via metallothionein induction. | 1.02e-11 | 8 | 23 | 4 | 25496228 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 24440343 | ||
| Pubmed | Dual Opposing Roles of Metallothionein Overexpression in C57BL/6J Mouse Pancreatic β-Cells. | 1.02e-11 | 8 | 23 | 4 | 26335571 | |
| Pubmed | Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart. | 1.02e-11 | 8 | 23 | 4 | 22523246 | |
| Pubmed | Transgenic mouse blastocysts that overexpress metallothionein-I resist cadmium toxicity in vitro. | 1.02e-11 | 8 | 23 | 4 | 8824913 | |
| Pubmed | Dietary zinc and metallothionein on small intestinal disaccharidases activity in mice. | 1.02e-11 | 8 | 23 | 4 | 21253395 | |
| Pubmed | Mouse liver metallothioneins. Complete amino acid sequence of metallothionein-I. | 1.02e-11 | 8 | 23 | 4 | 914867 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 8415626 | ||
| Pubmed | Protective role of metallothionein against copper depletion. | 1.02e-11 | 8 | 23 | 4 | 16759633 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 19490933 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 6276022 | ||
| Pubmed | Hypothermia enhances induction of protective protein metallothionein under ischemia. | 1.02e-11 | 8 | 23 | 4 | 23374901 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 29269399 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 21866758 | ||
| Pubmed | Influence of NH-Sgamma bonding interactions on the structure and dynamics of metallothioneins. | 1.02e-11 | 8 | 23 | 4 | 19609577 | |
| Pubmed | Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering. | 1.02e-11 | 8 | 23 | 4 | 8495976 | |
| Pubmed | Cloning and sequencing of cDNA for mouse liver metallothionein-I. | 1.02e-11 | 8 | 23 | 4 | 6277322 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 33964119 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 33532613 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 7645027 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 10830785 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 21467744 | ||
| Pubmed | Metallothionein mediates the level and activity of nuclear factor kappa B in murine fibroblasts. | 1.02e-11 | 8 | 23 | 4 | 15039454 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 24284788 | ||
| Pubmed | Metallothionein-human GH fusion genes stimulate growth of mice. | 1.02e-11 | 8 | 23 | 4 | 6356363 | |
| Pubmed | Heme-hemopexin-mediated induction of metallothionein gene expression. | 1.02e-11 | 8 | 23 | 4 | 1644822 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 20127815 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 28134760 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 32415999 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 19914257 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 7254320 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 20056912 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 19344729 | ||
| Pubmed | CpG Site-Specific Regulation of Metallothionein-1 Gene Expression. | 1.02e-11 | 8 | 23 | 4 | 32824906 | |
| Pubmed | Differential expression of the metallothionein gene in liver and brain of mice and rats. | 1.02e-11 | 8 | 23 | 4 | 8470112 | |
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 12638735 | ||
| Pubmed | 1.02e-11 | 8 | 23 | 4 | 19386279 | ||
| Pubmed | Chromosome assignments of genes for rat ceruloplasmin (CP) and metallothionein (MT). | 1.02e-11 | 8 | 23 | 4 | 8404063 | |
| Pubmed | Zinc, immune plasticity, aging, and successful aging: role of metallothionein. | 1.02e-11 | 8 | 23 | 4 | 15247005 | |
| Pubmed | Fine mapping of a mouse metallothionein gene metal response element. | 1.02e-11 | 8 | 23 | 4 | 2725504 | |
| Pubmed | Cloning and characterization of the metallothionein-I gene from mouse LMTK cells. | 1.02e-11 | 8 | 23 | 4 | 2824133 | |
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 18579766 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 22363575 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 1779826 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 17455258 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 8118873 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 20798270 | ||
| Pubmed | Intermittent hypoxia-induced cardiomyopathy and its prevention by Nrf2 and metallothionein. | 1.83e-11 | 9 | 23 | 4 | 28778483 | |
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 16049321 | ||
| Pubmed | Using MT(-/-) mice to study metallothionein and oxidative stress. | 1.83e-11 | 9 | 23 | 4 | 10699757 | |
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 16432836 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 10495773 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 23467591 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 30557628 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 10505629 | ||
| Pubmed | Cadmium-induced mRNA expression of Hsp32 is augmented in metallothionein-I and -II knock-out mice. | 1.83e-11 | 9 | 23 | 4 | 11051100 | |
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 1588441 | ||
| Pubmed | DNA variants with telomere probe enable genetic mapping of ends of mouse chromosomes. | 1.83e-11 | 9 | 23 | 4 | 1686839 | |
| Pubmed | Mammalian MT1 and MT2 metallothioneins differ in their metal binding abilities. | 1.83e-11 | 9 | 23 | 4 | 23925449 | |
| Pubmed | Down-regulation of metallothionein 1 and 2 after exposure to electromagnetic field in mouse testis. | 1.83e-11 | 9 | 23 | 4 | 22395140 | |
| Pubmed | Metallothionein 1+2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide. | 1.83e-11 | 9 | 23 | 4 | 11835189 | |
| Pubmed | Infection of metallothionein 1+2 knockout mice with Rocky Mountain Laboratory scrapie. | 1.83e-11 | 9 | 23 | 4 | 18221736 | |
| Pubmed | Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma. | 1.83e-11 | 9 | 23 | 4 | 15743795 | |
| Pubmed | Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. | 1.83e-11 | 9 | 23 | 4 | 8290567 | |
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 27403038 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 15639482 | ||
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 15161632 | ||
| Pubmed | Role of metallothioneins as danger signals in the pathogenesis of colitis. | 1.83e-11 | 9 | 23 | 4 | 24452846 | |
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 11850030 | ||
| Pubmed | Metallothionein-I/II knockout mice are sensitive to acetaminophen-induced hepatotoxicity. | 1.83e-11 | 9 | 23 | 4 | 10087053 | |
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 21035574 | ||
| Pubmed | Deficiency of metallothionein-1 and -2 genes shortens the lifespan of the 129/Sv mouse strain. | 1.83e-11 | 9 | 23 | 4 | 25871729 | |
| Pubmed | Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength. | 1.83e-11 | 9 | 23 | 4 | 27956698 | |
| Pubmed | Regulation, linkage, and sequence of mouse metallothionein I and II genes. | 1.83e-11 | 9 | 23 | 4 | 6095054 | |
| Pubmed | 1.83e-11 | 9 | 23 | 4 | 18239062 | ||
| Interaction | SMCP interactions | KRTAP5-4 KRTAP5-9 LCE1B LCE1E MT1B LCE1D LCE1A MT1M LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 8.83e-27 | 79 | 22 | 13 | int:SMCP |
| Interaction | LCE4A interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.05e-26 | 80 | 22 | 13 | int:LCE4A |
| Interaction | KRTAP4-4 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.25e-26 | 81 | 22 | 13 | int:KRTAP4-4 |
| Interaction | LCE2C interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 4.00e-26 | 88 | 22 | 13 | int:LCE2C |
| Interaction | LCE1F interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 7.43e-26 | 92 | 22 | 13 | int:LCE1F |
| Interaction | KRTAP5-6 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.00e-25 | 94 | 22 | 13 | int:KRTAP5-6 |
| Interaction | KRTAP5-4 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.80e-25 | 63 | 22 | 12 | int:KRTAP5-4 |
| Interaction | KRTAP5-11 interactions | KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 3.33e-25 | 66 | 22 | 12 | int:KRTAP5-11 |
| Interaction | KRTAP5-3 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP1-5 KRTAP1-1 KRTAP1-3 | 3.33e-25 | 66 | 22 | 12 | int:KRTAP5-3 |
| Interaction | LCE1E interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 4.91e-25 | 68 | 22 | 12 | int:LCE1E |
| Interaction | LCE2A interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 5.95e-25 | 69 | 22 | 12 | int:LCE2A |
| Interaction | KRTAP10-5 interactions | MT1DP KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 6.70e-25 | 160 | 22 | 14 | int:KRTAP10-5 |
| Interaction | LCE1D interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 7.17e-25 | 70 | 22 | 12 | int:LCE1D |
| Interaction | LCE3B interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE1F KRTAP5-11 KRTAP1-1 KRTAP1-3 | 1.66e-24 | 46 | 22 | 11 | int:LCE3B |
| Interaction | KRTAP4-5 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP1-5 KRTAP1-1 KRTAP1-3 | 2.09e-24 | 76 | 22 | 12 | int:KRTAP4-5 |
| Interaction | LCE2B interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP1-5 KRTAP1-1 KRTAP1-3 | 4.74e-24 | 81 | 22 | 12 | int:LCE2B |
| Interaction | LCE1A interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 7.57e-24 | 84 | 22 | 12 | int:LCE1A |
| Interaction | LCE1B interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 8.81e-24 | 85 | 22 | 12 | int:LCE1B |
| Interaction | KRTAP4-2 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.05e-23 | 132 | 22 | 13 | int:KRTAP4-2 |
| Interaction | LCE5A interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 1.83e-23 | 90 | 22 | 12 | int:LCE5A |
| Interaction | KRTAP4-11 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP1-5 KRTAP1-1 KRTAP1-3 | 2.42e-23 | 92 | 22 | 12 | int:KRTAP4-11 |
| Interaction | KRTAP9-2 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 5.43e-23 | 149 | 22 | 13 | int:KRTAP9-2 |
| Interaction | KRTAP5-2 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E MT1B LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 | 6.28e-23 | 62 | 22 | 11 | int:KRTAP5-2 |
| Interaction | KRTAP9-8 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-1 KRTAP1-3 | 6.98e-23 | 100 | 22 | 12 | int:KRTAP9-8 |
| Interaction | KRTAP10-1 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 7.76e-23 | 153 | 22 | 13 | int:KRTAP10-1 |
| Interaction | LCE2D interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE1F KRTAP1-5 KRTAP1-1 KRTAP1-3 | 5.13e-22 | 74 | 22 | 11 | int:LCE2D |
| Interaction | CYSRT1 interactions | ZCCHC14 KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 MT1M LCE1F KRTAP5-11 KRTAP1-5 SLIT1 KRTAP1-1 KRTAP1-3 | 1.50e-21 | 511 | 22 | 16 | int:CYSRT1 |
| Interaction | KRTAP5-9 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 MT1M LCE1F KRTAP5-11 KRTAP1-1 KRTAP1-3 | 3.42e-21 | 203 | 22 | 13 | int:KRTAP5-9 |
| Interaction | KRTAP9-3 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-1 KRTAP1-3 | 4.76e-21 | 140 | 22 | 12 | int:KRTAP9-3 |
| Interaction | KRTAP10-11 interactions | KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP1-1 KRTAP1-3 | 3.13e-20 | 64 | 22 | 10 | int:KRTAP10-11 |
| Interaction | KRTAP10-9 interactions | MT1DP KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-1 KRTAP1-3 | 3.34e-20 | 241 | 22 | 13 | int:KRTAP10-9 |
| Interaction | LCE1C interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 | 2.25e-19 | 77 | 22 | 10 | int:LCE1C |
| Interaction | KRTAP4-12 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP1-1 KRTAP1-3 | 3.91e-18 | 161 | 22 | 11 | int:KRTAP4-12 |
| Interaction | CRCT1 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-3 | 1.18e-17 | 66 | 22 | 9 | int:CRCT1 |
| Interaction | KRTAP10-8 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 SLIT1 KRTAP1-1 KRTAP1-3 | 2.67e-17 | 401 | 22 | 13 | int:KRTAP10-8 |
| Interaction | CATSPER1 interactions | KRTAP5-4 KRTAP5-9 LCE1B LCE1E LCE1D LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 3.85e-17 | 126 | 22 | 10 | int:CATSPER1 |
| Interaction | KRTAP1-1 interactions | KRTAP5-4 KRTAP5-9 LCE1B LCE1E MT1B LCE1D LCE1A LCE1F KRTAP5-11 SLIT1 KRTAP1-1 | 1.23e-16 | 219 | 22 | 11 | int:KRTAP1-1 |
| Interaction | KRTAP1-5 interactions | 1.75e-16 | 48 | 22 | 8 | int:KRTAP1-5 | |
| Interaction | RGS17 interactions | 1.75e-16 | 48 | 22 | 8 | int:RGS17 | |
| Interaction | KRTAP10-6 interactions | KRTAP5-4 KRTAP5-9 LCE1B LCE1E MT1B LCE1D LCE1A LCE1F KRTAP5-11 | 1.80e-16 | 88 | 22 | 9 | int:KRTAP10-6 |
| Interaction | KRTAP2-3 interactions | KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE1F KRTAP5-11 KRTAP1-1 | 3.69e-16 | 95 | 22 | 9 | int:KRTAP2-3 |
| Interaction | HOXA1 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1D LCE1A LCE1F KRTAP5-11 KRTAP1-5 SLIT1 KRTAP1-1 KRTAP1-3 | 4.24e-16 | 356 | 22 | 12 | int:HOXA1 |
| Interaction | KRTAP2-4 interactions | KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE1F KRTAP5-11 KRTAP1-1 | 6.53e-16 | 101 | 22 | 9 | int:KRTAP2-4 |
| Interaction | SPRY1 interactions | KRTAP5-9 LCE1C LCE1B LCE1E LCE1D LCE1A LCE1F KRTAP1-1 KRTAP1-3 | 1.57e-15 | 111 | 22 | 9 | int:SPRY1 |
| Interaction | KRTAP12-1 interactions | 1.78e-15 | 63 | 22 | 8 | int:KRTAP12-1 | |
| Interaction | KRTAP1-3 interactions | KRTAP5-4 KRTAP5-9 LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 KRTAP1-3 | 1.85e-15 | 184 | 22 | 10 | int:KRTAP1-3 |
| Interaction | RGS20 interactions | KRTAP5-4 KRTAP5-9 LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 | 2.77e-15 | 118 | 22 | 9 | int:RGS20 |
| Interaction | LCE3C interactions | KRTAP5-4 KRTAP5-9 LCE1B LCE1A LCE1F KRTAP5-11 KRTAP1-1 KRTAP1-3 | 2.98e-15 | 67 | 22 | 8 | int:LCE3C |
| Interaction | ALPP interactions | KRTAP5-9 LCE1C LCE1B LCE1E LCE1D CRCT1 LCE1F KRTAP1-1 KRTAP1-3 | 4.06e-15 | 123 | 22 | 9 | int:ALPP |
| Interaction | CHIC2 interactions | 6.13e-15 | 73 | 22 | 8 | int:CHIC2 | |
| Interaction | LCE3A interactions | KRTAP5-4 KRTAP5-9 LCE1C CRCT1 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 8.58e-15 | 76 | 22 | 8 | int:LCE3A |
| Interaction | ADAMTSL4 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1D LCE1A LCE1F KRTAP1-5 SLIT1 KRTAP1-1 | 9.83e-15 | 217 | 22 | 10 | int:ADAMTSL4 |
| Interaction | KRTAP12-3 interactions | 1.97e-14 | 146 | 22 | 9 | int:KRTAP12-3 | |
| Interaction | OTX1 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1B LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 3.40e-14 | 155 | 22 | 9 | int:OTX1 |
| Interaction | KRTAP5-7 interactions | 8.13e-13 | 71 | 22 | 7 | int:KRTAP5-7 | |
| Interaction | TRIM42 interactions | 2.16e-12 | 149 | 22 | 8 | int:TRIM42 | |
| Interaction | VASN interactions | KRTAP5-4 LCE1C LCE1B LCE1A LCE1F KRTAP5-11 KRTAP1-1 KRTAP1-3 | 3.85e-12 | 160 | 22 | 8 | int:VASN |
| Interaction | CREB5 interactions | KRTAP5-4 KRTAP5-9 LCE1C LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 4.70e-12 | 164 | 22 | 8 | int:CREB5 |
| Interaction | KRTAP10-7 interactions | KRTAP5-4 KRTAP5-9 LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 | 1.08e-11 | 293 | 22 | 9 | int:KRTAP10-7 |
| Interaction | LCE3E interactions | 3.87e-11 | 60 | 22 | 6 | int:LCE3E | |
| Interaction | KRTAP10-10 interactions | 7.56e-11 | 27 | 22 | 5 | int:KRTAP10-10 | |
| Interaction | NBPF19 interactions | 7.87e-11 | 233 | 22 | 8 | int:NBPF19 | |
| Interaction | NOTCH2NLA interactions | KRTAP5-4 KRTAP5-9 LCE1B LCE1E LCE1D LCE1A CRCT1 LCE1F KRTAP5-11 | 1.12e-10 | 381 | 22 | 9 | int:NOTCH2NLA |
| Interaction | LCE3D interactions | 1.31e-10 | 73 | 22 | 6 | int:LCE3D | |
| Interaction | KRTAP4-1 interactions | 1.59e-10 | 31 | 22 | 5 | int:KRTAP4-1 | |
| Interaction | NUFIP2 interactions | KRTAP5-4 KRTAP5-9 LCE1B LCE1D LCE1F KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 2.50e-10 | 417 | 22 | 9 | int:NUFIP2 |
| Interaction | POU4F2 interactions | 2.87e-10 | 83 | 22 | 6 | int:POU4F2 | |
| Interaction | GRN interactions | 3.49e-10 | 281 | 22 | 8 | int:GRN | |
| Interaction | KRTAP11-1 interactions | 1.43e-09 | 108 | 22 | 6 | int:KRTAP11-1 | |
| Interaction | KRTAP17-1 interactions | 1.58e-09 | 48 | 22 | 5 | int:KRTAP17-1 | |
| Interaction | KRTAP12-4 interactions | 2.64e-09 | 53 | 22 | 5 | int:KRTAP12-4 | |
| Interaction | CRH interactions | 7.69e-09 | 22 | 22 | 4 | int:CRH | |
| Interaction | NECTIN2 interactions | 1.47e-08 | 159 | 22 | 6 | int:NECTIN2 | |
| Interaction | MEOX2 interactions | MT1DP KRTAP5-4 KRTAP5-9 LCE1B LCE1E LCE1D CRCT1 KRTAP5-11 SLIT1 | 2.23e-08 | 697 | 22 | 9 | int:MEOX2 |
| Interaction | MACO1 interactions | 2.62e-08 | 175 | 22 | 6 | int:MACO1 | |
| Interaction | CYP21A2 interactions | 4.27e-08 | 33 | 22 | 4 | int:CYP21A2 | |
| Interaction | CHRD interactions | 4.90e-08 | 94 | 22 | 5 | int:CHRD | |
| Interaction | WNT11 interactions | 5.45e-08 | 35 | 22 | 4 | int:WNT11 | |
| Interaction | KRTAP12-2 interactions | 2.31e-07 | 128 | 22 | 5 | int:KRTAP12-2 | |
| Interaction | FBLN1 interactions | 2.40e-07 | 129 | 22 | 5 | int:FBLN1 | |
| Interaction | SPRY2 interactions | 5.43e-07 | 152 | 22 | 5 | int:SPRY2 | |
| Interaction | VWC2 interactions | 5.70e-07 | 62 | 22 | 4 | int:VWC2 | |
| Interaction | KRTAP6-3 interactions | 7.21e-07 | 161 | 22 | 5 | int:KRTAP6-3 | |
| Interaction | LELP1 interactions | 7.60e-07 | 17 | 22 | 3 | int:LELP1 | |
| Interaction | TGFB1 interactions | 8.72e-07 | 317 | 22 | 6 | int:TGFB1 | |
| Interaction | MT1M interactions | 9.12e-07 | 18 | 22 | 3 | int:MT1M | |
| Interaction | PLSCR4 interactions | 1.23e-06 | 75 | 22 | 4 | int:PLSCR4 | |
| Interaction | NECTIN3 interactions | 1.44e-06 | 78 | 22 | 4 | int:NECTIN3 | |
| Interaction | SLC39A7 interactions | 1.51e-06 | 187 | 22 | 5 | int:SLC39A7 | |
| Interaction | CHRNG interactions | 1.97e-06 | 23 | 22 | 3 | int:CHRNG | |
| Interaction | NMU interactions | 2.03e-06 | 85 | 22 | 4 | int:NMU | |
| Interaction | DMRT3 interactions | 2.23e-06 | 87 | 22 | 4 | int:DMRT3 | |
| Interaction | SHFL interactions | 3.45e-06 | 97 | 22 | 4 | int:SHFL | |
| Interaction | PCSK5 interactions | 6.12e-06 | 112 | 22 | 4 | int:PCSK5 | |
| Interaction | KLK8 interactions | 7.22e-06 | 35 | 22 | 3 | int:KLK8 | |
| Interaction | SPRY3 interactions | 7.22e-06 | 35 | 22 | 3 | int:SPRY3 | |
| Interaction | HOXB9 interactions | 9.17e-06 | 124 | 22 | 4 | int:HOXB9 | |
| Interaction | ZNF440 interactions | 1.09e-05 | 40 | 22 | 3 | int:ZNF440 | |
| Interaction | VWC2L interactions | 1.09e-05 | 40 | 22 | 3 | int:VWC2L | |
| Interaction | FUCA2 interactions | 1.35e-05 | 43 | 22 | 3 | int:FUCA2 | |
| Cytoband | 16q13 | 1.50e-14 | 36 | 23 | 6 | 16q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q13 | 2.95e-14 | 40 | 23 | 6 | chr16q13 | |
| Cytoband | 1q21.3 | 2.34e-11 | 117 | 23 | 6 | 1q21.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 8.43e-10 | 404 | 23 | 7 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 3.28e-06 | 473 | 23 | 5 | chr17q21 | |
| Cytoband | 17q12-q21 | 1.18e-04 | 32 | 23 | 2 | 17q12-q21 | |
| Cytoband | 17q21.2 | 5.68e-04 | 70 | 23 | 2 | 17q21.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 2.15e-02 | 454 | 23 | 2 | chr11q13 | |
| GeneFamily | Late cornified envelope proteins | 2.06e-14 | 18 | 21 | 6 | 627 | |
| GeneFamily | Metallothioneins | 3.01e-14 | 19 | 21 | 6 | 638 | |
| GeneFamily | Keratin associated proteins | KRTAP5-4 KRTAP5-9 KRTAP9-9 KRTAP1-4 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 2.56e-13 | 109 | 21 | 8 | 619 |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | LCE1C LCE1B LCE1E MT1B LCE1D MT1E LCE1A KRTAP9-9 KRTAP1-5 KRTAP1-3 | 6.84e-16 | 204 | 23 | 10 | MM966 |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 6.07e-10 | 49 | 23 | 5 | MM452 | |
| Coexpression | VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP | 3.26e-09 | 22 | 23 | 4 | MM1299 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 7.80e-09 | 27 | 23 | 4 | MM643 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP | 9.09e-09 | 28 | 23 | 4 | MM487 | |
| Coexpression | BRACHAT_RESPONSE_TO_METHOTREXATE_DN | 3.26e-08 | 38 | 23 | 4 | MM1161 | |
| Coexpression | RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP | 3.30e-08 | 8 | 23 | 3 | M41082 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 3.80e-08 | 630 | 23 | 8 | MM1038 | |
| Coexpression | HOUSTIS_ROS | 5.97e-08 | 44 | 23 | 4 | MM1142 | |
| Coexpression | MA_MYELOID_DIFFERENTIATION_UP | 7.17e-08 | 46 | 23 | 4 | MM640 | |
| Coexpression | SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP | 8.54e-08 | 48 | 23 | 4 | MM649 | |
| Coexpression | PIONTEK_PKD1_TARGETS_UP | 1.10e-07 | 51 | 23 | 4 | MM794 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_VENTRICULAR_ZONE | 1.19e-07 | 52 | 23 | 4 | MM442 | |
| Coexpression | WANG_TARGETS_OF_MLL_CBP_FUSION_UP | 1.19e-07 | 52 | 23 | 4 | MM628 | |
| Coexpression | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN | 1.38e-07 | 54 | 23 | 4 | MM1195 | |
| Coexpression | LEIN_ASTROCYTE_MARKERS | 1.38e-07 | 54 | 23 | 4 | MM715 | |
| Coexpression | JIANG_AGING_HYPOTHALAMUS_UP | 1.85e-07 | 58 | 23 | 4 | MM703 | |
| Coexpression | GUILLAUMOND_KLF10_TARGETS_UP | 1.99e-07 | 59 | 23 | 4 | MM952 | |
| Coexpression | NAKAMURA_ADIPOGENESIS_EARLY_UP | 2.59e-07 | 63 | 23 | 4 | M2024 | |
| Coexpression | ZHENG_RESPONSE_TO_ARSENITE_UP | 2.67e-07 | 15 | 23 | 3 | M1589 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 3.61e-07 | 173 | 23 | 5 | M650 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 8.30e-07 | 84 | 23 | 4 | MM873 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 9.69e-07 | 650 | 23 | 7 | MM1042 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 1.06e-06 | 659 | 23 | 7 | MM1040 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_UP | 1.25e-06 | 93 | 23 | 4 | MM850 | |
| Coexpression | ZHANG_UTERUS_C2_REGENERATIVE_UP | 1.48e-06 | 97 | 23 | 4 | MM16605 | |
| Coexpression | HUMMERICH_SKIN_CANCER_PROGRESSION_UP | 1.67e-06 | 100 | 23 | 4 | MM514 | |
| Coexpression | PASINI_SUZ12_TARGETS_UP | 4.07e-06 | 125 | 23 | 4 | MM1065 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_CARDIOMYOCYTE_AGEING | 4.20e-06 | 126 | 23 | 4 | MM3711 | |
| Coexpression | MA_RAT_AGING_UP | 4.33e-06 | 127 | 23 | 4 | MM16096 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_MACROPHAGE_AGEING | 4.47e-06 | 128 | 23 | 4 | MM3838 | |
| Coexpression | GROSS_HYPOXIA_VIA_HIF1A_DN | 4.90e-06 | 131 | 23 | 4 | MM1127 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 5.69e-06 | 136 | 23 | 4 | MM3747 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP | 6.03e-06 | 138 | 23 | 4 | MM1047 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_HIGH_UP | 1.54e-05 | 175 | 23 | 4 | MM499 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP | 1.54e-05 | 175 | 23 | 4 | MM501 | |
| Coexpression | ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP | 1.57e-05 | 176 | 23 | 4 | MM1048 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP | 1.92e-05 | 185 | 23 | 4 | MM1115 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 1.96e-05 | 186 | 23 | 4 | MM498 | |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_MESENCHYMAL_STEM_CELL_AGEING | 2.40e-05 | 196 | 23 | 4 | MM3746 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_22 | 3.21e-05 | 211 | 23 | 4 | MM17089 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING | 3.27e-05 | 212 | 23 | 4 | MM3816 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_FIBROBLAST_OF_LUNG_AGEING | 4.05e-05 | 224 | 23 | 4 | MM3767 | |
| Coexpression | DARWICHE_SKIN_TUMOR_PROMOTER_DN | 4.12e-05 | 225 | 23 | 4 | MM496 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 4.64e-05 | 232 | 23 | 4 | MM1019 | |
| Coexpression | TABULA_MURIS_SENIS_LUNG_ADVENTITIAL_CELL_AGEING | 4.80e-05 | 234 | 23 | 4 | MM3761 | |
| Coexpression | LUDWICZEK_TREATING_IRON_OVERLOAD | 4.84e-05 | 12 | 23 | 2 | MM792 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_DN | 8.00e-05 | 267 | 23 | 4 | MM1091 | |
| Coexpression | TABULA_MURIS_SENIS_DIAPHRAGM_SKELETAL_MUSCLE_SATELLITE_CELL_AGEING | 8.36e-05 | 270 | 23 | 4 | MM3696 | |
| Coexpression | PLASARI_TGFB1_TARGETS_10HR_DN | 8.48e-05 | 271 | 23 | 4 | MM1075 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP | 8.77e-05 | 16 | 23 | 2 | MM1089 | |
| Coexpression | TABULA_MURIS_SENIS_LIVER_NK_CELL_AGEING | 1.07e-04 | 288 | 23 | 4 | MM3751 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 1.15e-04 | 569 | 23 | 5 | M12701 | |
| Coexpression | PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP | 1.21e-04 | 297 | 23 | 4 | MM1003 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_B_CELL_AGEING | 1.51e-04 | 315 | 23 | 4 | MM3784 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | 1.55e-04 | 317 | 23 | 4 | MM956 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 1.60e-04 | 610 | 23 | 5 | M3854 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 1.66e-04 | 615 | 23 | 5 | M8673 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 1.75e-04 | 327 | 23 | 4 | MM3714 | |
| Coexpression | SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP | 1.84e-04 | 23 | 23 | 2 | MM1198 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_CELL_AGEING | 1.85e-04 | 332 | 23 | 4 | MM3679 | |
| Coexpression | LI_INDUCED_T_TO_NATURAL_KILLER_UP | 2.10e-04 | 343 | 23 | 4 | MM1059 | |
| Coexpression | BENPORATH_PRC2_TARGETS | 2.14e-04 | 650 | 23 | 5 | M8448 | |
| Coexpression | BENPORATH_EED_TARGETS | 2.40e-04 | 1059 | 23 | 6 | M7617 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN | 2.49e-04 | 141 | 23 | 3 | M11896 | |
| Coexpression | TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP | 2.75e-04 | 28 | 23 | 2 | MM707 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 2.77e-04 | 369 | 23 | 4 | MM16610 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | 2.81e-04 | 689 | 23 | 5 | MM1041 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 2.90e-04 | 694 | 23 | 5 | MM1039 | |
| Coexpression | ZHANG_UTERUS_C13_EPITHELIAL1_CELL | 3.25e-04 | 385 | 23 | 4 | MM16619 | |
| Coexpression | TABULA_MURIS_SENIS_DIAPHRAGM_MESENCHYMAL_STEM_CELL_AGEING | 3.65e-04 | 397 | 23 | 4 | MM3695 | |
| Coexpression | GOLDRATH_ANTIGEN_RESPONSE | 3.65e-04 | 397 | 23 | 4 | MM1255 | |
| Coexpression | PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN | 3.75e-04 | 162 | 23 | 3 | M1459 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 3.83e-04 | 402 | 23 | 4 | MM1248 | |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_ENDOTHELIAL_CELL_AGEING | 4.44e-04 | 418 | 23 | 4 | MM3681 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_DN | 4.56e-04 | 421 | 23 | 4 | MM985 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 5.03e-04 | 432 | 23 | 4 | MM419 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 5.16e-04 | 435 | 23 | 4 | MM1221 | |
| Coexpression | GSE3982_BCELL_VS_TH2_DN | 6.83e-04 | 199 | 23 | 3 | M5555 | |
| Coexpression | NAKAJIMA_MAST_CELL | 7.45e-04 | 46 | 23 | 2 | M389 | |
| Coexpression | AMUNDSON_RESPONSE_TO_ARSENITE | 9.01e-04 | 219 | 23 | 3 | M262 | |
| Coexpression | SUNG_METASTASIS_STROMA_DN | 1.03e-03 | 54 | 23 | 2 | M2904 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | 1.11e-03 | 534 | 23 | 4 | MM1050 | |
| Coexpression | ACEVEDO_LIVER_CANCER_DN | 1.16e-03 | 540 | 23 | 4 | M7577 | |
| Coexpression | PILON_KLF1_TARGETS_UP | 1.16e-03 | 541 | 23 | 4 | MM1061 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_T_CELL_AGEING | 1.20e-03 | 545 | 23 | 4 | MM3785 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR | 1.22e-03 | 548 | 23 | 4 | MM1013 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | 1.23e-03 | 954 | 23 | 5 | MM3689 | |
| Coexpression | NADLER_OBESITY_UP | 1.57e-03 | 67 | 23 | 2 | MM1007 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN | 1.72e-03 | 70 | 23 | 2 | MM994 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_UP | 1.75e-03 | 1033 | 23 | 5 | M4196 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 1.77e-03 | 1035 | 23 | 5 | M9898 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 2.45e-03 | 1115 | 23 | 5 | M10371 | |
| Coexpression | GHANDHI_BYSTANDER_IRRADIATION_UP | 2.46e-03 | 84 | 23 | 2 | M2597 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_6_7WK_DN | 2.63e-03 | 87 | 23 | 2 | MM992 | |
| Coexpression | SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER | 2.69e-03 | 88 | 23 | 2 | M11288 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_ACINAR_CELLS | 2.81e-03 | 90 | 23 | 2 | M40267 | |
| Coexpression | GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN | 3.00e-03 | 93 | 23 | 2 | MM1149 | |
| Coexpression | TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING | 3.26e-03 | 97 | 23 | 2 | MM3789 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_HEMATOPOIETIC_STEM_CELL_AGEING | 3.31e-03 | 721 | 23 | 4 | MM3800 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_250 | 8.78e-09 | 206 | 17 | 6 | Facebase_ST1_Univ_250 | |
| CoexpressionAtlas | skin | 3.25e-08 | 456 | 17 | 7 | skin | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500 | 6.55e-07 | 427 | 17 | 6 | Facebase_ST1_Univ_500 | |
| CoexpressionAtlas | Pluripotent Stem Cells-reprogram_NA_vs_Pluripotent Stem Cells-reprogram_OS-NL-Confounder_removed-fold2.0_adjp0.05 | 3.12e-05 | 78 | 17 | 3 | PCBC_ratio_ESC_vs_iPSC_method-OS-NL_cfr-2X-p05 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_3 | 3.63e-05 | 82 | 17 | 3 | Facebase_ST1_Univ_500_3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_100 | 6.37e-05 | 99 | 17 | 3 | PCBC_ctl_BronchSmoothMuscl_100 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells-method_NA_vs_Ectoderm Differentiated Cells-method_plasmid-Confounder_removed-fold2.0_adjp0.05 | 6.97e-05 | 102 | 17 | 3 | PCBC_ratio_ECTO_from-ESC_vs_ECTO_from-plasmid_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | 7.64e-05 | 981 | 17 | 6 | PCBC_ctl_BronchSmoothMuscl_1000 | |
| CoexpressionAtlas | ECTO amniotic fluid MSC_vs_ECTO blastocyst-Confounder_removed-fold2.0_adjp0.05 | 3.92e-04 | 183 | 17 | 3 | PCBC_ratio_ECTO amniotic fluid MSC_vs_ECTO blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_500 | 5.21e-04 | 489 | 17 | 4 | PCBC_ctl_BronchSmoothMuscl_500 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_NA_vs_Endoderm Differentiated Cells-reprogram_OSKM-L-Confounder_removed-fold2.0_adjp0.05 | 5.85e-04 | 45 | 17 | 2 | PCBC_ratio_DE_from-ESC_vs_DE_from-OSKM-L_cfr-2X-p05 | |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_NA_vs_Endoderm Differentiated Cells-method_mRNA-Confounder_removed-fold2.0_adjp0.05 | 5.85e-04 | 45 | 17 | 2 | PCBC_ratio_DE_from-ESC_vs_DE_from-mRNA_cfr-2X-p05 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_500_5 | 6.94e-04 | 49 | 17 | 2 | Facebase_ST1_Univ_500_5 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.16e-03 | 266 | 17 | 3 | Arv_SC-hpx_blastocyst_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K1 | 1.45e-03 | 71 | 17 | 2 | facebase_RNAseq_e9.5_MaxArch_2500_K1 | |
| CoexpressionAtlas | UniversalReference_WholeMouseP1_top-relative-expression-ranked_100 | 2.02e-03 | 84 | 17 | 2 | Facebase_ST1_Univ_100 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP5-4 KRTAP5-9 KRTAP9-9 KRTAP1-4 KRTAP5-11 KRTAP1-5 KRTAP1-1 KRTAP1-3 | 4.76e-15 | 146 | 23 | 8 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor-3|TCGA-Testes / Sample_Type by Project: Shred V9 | 4.94e-09 | 125 | 23 | 5 | 5f90de494b53ecce6455034f3ed5dccdbb2c29ca | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.47e-07 | 129 | 23 | 4 | 6a201c6344a015e5cf2f79ccf397fd7ad66b6768 | |
| ToppCell | lung-Club_Cells|lung / shred on tissue and cell subclass | 1.43e-06 | 164 | 23 | 4 | b12cacd499b18b96120ca6d14646aebeaed41d10 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-06 | 173 | 23 | 4 | 0f9c1d3298e59e6d22bb3306f0f445f490be8bbd | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.46e-06 | 188 | 23 | 4 | 1a751452c0f1f34b3c20fad2fb52c378ab2d0207 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.56e-06 | 190 | 23 | 4 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.56e-06 | 190 | 23 | 4 | ad0d9aed8c9c99551765d14730d70ebef1ea856b | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.56e-06 | 190 | 23 | 4 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.56e-06 | 190 | 23 | 4 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 2.67e-06 | 192 | 23 | 4 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | IPF-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 2.78e-06 | 194 | 23 | 4 | d8a26da856a85e3d001d406e992cb18fdd58baef | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.90e-06 | 196 | 23 | 4 | 5cc14a5797884ff3a007683048e690a0d7172fc4 | |
| ToppCell | medial-2-Endothelial-Capillary_Intermediate_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.90e-06 | 196 | 23 | 4 | d074c24fecd0e3ffca4699fb1a9d443e6d9a858d | |
| ToppCell | medial-Endothelial-Capillary_Intermediate_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.90e-06 | 196 | 23 | 4 | 07e6214e771c65574f0ada65e75f4bda265aa47f | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 2.96e-06 | 197 | 23 | 4 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | medial|World / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.02e-06 | 198 | 23 | 4 | 071658de0c43f302172692aa0b4b507dbad7be50 | |
| ToppCell | medial-Endothelial-Artery|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.08e-06 | 199 | 23 | 4 | 341c0be18bec66f4cc8bda232dce54edb34b9cda | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.08e-06 | 199 | 23 | 4 | b44712baede833ddbac3699162b7eeb6ede2af27 | |
| ToppCell | medial-2-Endothelial-Artery|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.08e-06 | 199 | 23 | 4 | 53c17c0493f82351a039bc64def191311e0f4951 | |
| ToppCell | medial-Endothelial-Artery-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.08e-06 | 199 | 23 | 4 | c455f5a2802f2ec6f0e24266de1aaf3203ca8c78 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.08e-06 | 199 | 23 | 4 | a5c2c676fc0dd4f0422fbcae34ad6d734edd5349 | |
| ToppCell | distal-Endothelial-Artery-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.08e-06 | 199 | 23 | 4 | 3788f3218356aaaa10684e48d63757037f8a3a3c | |
| ToppCell | distal-Endothelial-Capillary-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-06 | 200 | 23 | 4 | ab96d3d801373459a2503ccfb665dc3f43bfb5a1 | |
| ToppCell | distal-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-06 | 200 | 23 | 4 | 7a355c3883fd409b2e0868164bb6e7ce4b745776 | |
| ToppCell | distal-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-06 | 200 | 23 | 4 | 8daf09d63c2fda6da6e5b66f96e7449ee8b17029 | |
| ToppCell | medial-2-Endothelial-Capillary|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-06 | 200 | 23 | 4 | e4f390dfd4dd25600f0f7a17c5523283a5966e92 | |
| ToppCell | medial-Endothelial-Capillary-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-06 | 200 | 23 | 4 | 4291b5453e98e20ec8150a96ccc865a5964bc645 | |
| ToppCell | medial-Endothelial-Capillary|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.14e-06 | 200 | 23 | 4 | fd4dcdc67db2a5dbdd54bd2ae975c66df904d4d8 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-7|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.48e-05 | 124 | 23 | 3 | c6e0c45e9ac128540baddfeb4599a0d5ec3f14cb | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.28e-05 | 133 | 23 | 3 | f7d0763b5eec2db33044d6850fd57462494038c1 | |
| ToppCell | IIF-Lymphocyte-T_NK-dnT|IIF / Disease, Lineage and Cell Type | 5.65e-05 | 146 | 23 | 3 | d0f361662db5f7be26104346e8431f7e30c5ce3a | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 7.98e-05 | 164 | 23 | 3 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_OR1J1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.13e-05 | 165 | 23 | 3 | 1f88f6939f88b80a0c98b4eef3684ba03c64ff7c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.57e-05 | 168 | 23 | 3 | 435ef2e4d702e978d54f9d1f5a047f39c691cc63 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells-RBC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.03e-05 | 171 | 23 | 3 | f21eae4dd2e0a566eff792d19367e96ffb0b74ba | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Red_blood_cells|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.03e-05 | 171 | 23 | 3 | d428c2859a1efc284610ca241a6dae9f182309cd | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.51e-05 | 174 | 23 | 3 | b31a6c9d8f7c8cb229c0539d959c19251e2fcd13 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.00e-04 | 177 | 23 | 3 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Primitive_erythrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.03e-04 | 179 | 23 | 3 | 3c8046f43da5a02fa4278a7175b9cd8cf95b8e27 | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 1.03e-04 | 179 | 23 | 3 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | COPD-Stromal-SMC|World / Disease state, Lineage and Cell class | 1.03e-04 | 179 | 23 | 3 | b2709537ec1b46457ab85261f4cdd354e60a8b29 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 180 | 23 | 3 | 18bf8561ad3aa9787d2a8ef942a96f641734c608 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 181 | 23 | 3 | 1c04e53f46992a0aea9d3eee985681ec4e71f80d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-Tuft-related-BEST4+_epithelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 181 | 23 | 3 | 83adf61f44cebe9e75de175c5dc39237fbf9ed24 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-04 | 183 | 23 | 3 | 8c8ce5a0d5535bef58ac10b7eb726f9c50af2ed8 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-04 | 183 | 23 | 3 | 263937906ddabc798bbe60f0da28ba859a5c72e2 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.14e-04 | 185 | 23 | 3 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 185 | 23 | 3 | d3b054d203e575c1bb5455aa7a2e551a0957a760 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 185 | 23 | 3 | b57dae20c21f984edd2acee4344d86f033108ebf | |
| ToppCell | COPD-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 1.16e-04 | 186 | 23 | 3 | 8adfd2d1fda4e8aecc95192ea627bf7ed5214b8d | |
| ToppCell | COPD-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 1.18e-04 | 187 | 23 | 3 | be42ee71d3412bb1f52593d8814de85c354a0efa | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 1.20e-04 | 188 | 23 | 3 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 1.20e-04 | 188 | 23 | 3 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-04 | 188 | 23 | 3 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 1.20e-04 | 188 | 23 | 3 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.21e-04 | 189 | 23 | 3 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.23e-04 | 190 | 23 | 3 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-04 | 190 | 23 | 3 | 799351fea7490d4159271d020c43c845ef37c788 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.23e-04 | 190 | 23 | 3 | ab56800abd1d5cbe2351834a1df749ac7db30892 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.25e-04 | 191 | 23 | 3 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-04 | 191 | 23 | 3 | b7713aba839e7a1f548b7b9d8893067bcc6d7ee7 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 192 | 23 | 3 | aedddccacf60e884af044cefba6c64ca10ac97d2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 192 | 23 | 3 | 859a32c9e4ed6961897b2ccaecde73a599471df9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 192 | 23 | 3 | 89e1da82fa2069dac7adb9cba3e8b6c0179e0dc5 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.27e-04 | 192 | 23 | 3 | f345b269c8cf06b004bc9419462dbc69bffaab89 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 192 | 23 | 3 | 389d5e6d0689371bfe1d0b06e92e0e6e5573567b | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.27e-04 | 192 | 23 | 3 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 193 | 23 | 3 | c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6 | |
| ToppCell | IPF-Endothelial-VE_Arterial|IPF / Disease state, Lineage and Cell class | 1.29e-04 | 193 | 23 | 3 | bf83b1fe9d38408f30eee4eb634341c04ef82791 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 193 | 23 | 3 | 682ce63b73a7d02eef240673db67058d7507f744 | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | 1.29e-04 | 193 | 23 | 3 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.29e-04 | 193 | 23 | 3 | a313541cedfcff8fb311b9bc60157359aa103830 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.29e-04 | 193 | 23 | 3 | 1e6e2d786511cc40241197368f5df20c20b882f3 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 194 | 23 | 3 | 87461bd6d7f702c0a0f5e0c8ace3049125a51f9a | |
| ToppCell | Macrophages-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 1.31e-04 | 194 | 23 | 3 | cbb1c65ccee58b2892f7d3fa45773099411c6104 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|COPD / Disease state, Lineage and Cell class | 1.31e-04 | 194 | 23 | 3 | 18b7f901c12ca4f21f9a1eafd092aefe4d668b6d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 194 | 23 | 3 | f4286ae7bb8350c42d50727ee8688b80129714f6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 194 | 23 | 3 | c578cf7c6b4d6f31f87dde8845de5b3891f16822 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 194 | 23 | 3 | ce599ed0dc181aea0584e426636de5098f34ebe6 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 1.31e-04 | 194 | 23 | 3 | 68705a6eca947c5b42b943d5224a7aef2a744007 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 194 | 23 | 3 | 79baee8b35b7707bbeb07c73b5e17b68bcd7bbc2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.31e-04 | 194 | 23 | 3 | f6e348f1f35c526cad6c349f1fdd0bd92d18aa3c | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class | 1.31e-04 | 194 | 23 | 3 | 169a304d5c13f08c39fad4116f093bc4a0765e9d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 195 | 23 | 3 | 667a2ed4b865e9a37674b3d154bb5bf2188b3ebf | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.33e-04 | 195 | 23 | 3 | c750602c765a51075ba6ede78e3ba80b62374481 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 195 | 23 | 3 | 83da75d210ae9c2a94018d70cb9e833b37004c4e | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-04 | 195 | 23 | 3 | 53b83e16b350100b1d5791a9c42bd98e37cbc0af | |
| ToppCell | ASK452|World / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.33e-04 | 195 | 23 | 3 | 7efd9d3a3f5e7dfe9698a4143ce4a0f9bf3a862c | |
| ToppCell | kidney_cells-Adult_normal_reference|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 196 | 23 | 3 | 902965bfc5726ca0f1f0a1f6fe3f6d701cc91e6b | |
| ToppCell | ILEUM-non-inflamed-(8)_Pericytes|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.35e-04 | 196 | 23 | 3 | b98fe1519e420d8b03c66e164bf4544f3dbb2e44 | |
| ToppCell | distal-2-Endothelial-Capillary_Intermediate_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.35e-04 | 196 | 23 | 3 | b84568f940f9473269fb1b14f3b3394b269e3945 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-B_(Artery)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.35e-04 | 196 | 23 | 3 | f540cf17b4405a6dd38d2b6123e6541d0aac889e | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.35e-04 | 196 | 23 | 3 | 19993604ee64ba85e3f53a784fcf1c934e862f61 | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.35e-04 | 196 | 23 | 3 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-04 | 197 | 23 | 3 | 1ab86f5c05a3d8f352420e62277d5c79933063d8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.37e-04 | 197 | 23 | 3 | 3f078be0b0f5e16edfb6d517beb20ac6178767f0 | |
| ToppCell | 3'-Distal_airway-Endothelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-04 | 197 | 23 | 3 | 9ffb823c0f3f23cc85f9fd3ca24f77817e90bd86 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.37e-04 | 197 | 23 | 3 | 608328608cef82adc867a449216839622253d486 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-04 | 197 | 23 | 3 | eb119e048d5ea1be5f427bb9fb60e5e7b6e84d92 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.11e-05 | 50 | 10 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_39_METAL_RESPONSE | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.32e-04 | 50 | 10 | 2 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.32e-04 | 50 | 10 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.32e-04 | 50 | 10 | 2 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_7 | |
| Drug | dicarboxymethyldithiocarbamate | 9.93e-11 | 9 | 23 | 4 | CID000130472 | |
| Drug | CAPSO-DTC | 9.93e-11 | 9 | 23 | 4 | CID003081023 | |
| Drug | 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine | 1.65e-10 | 10 | 23 | 4 | CID000819992 | |
| Drug | PmMT | 1.65e-10 | 10 | 23 | 4 | CID000085248 | |
| Drug | CAP-N-DTC | 2.60e-10 | 11 | 23 | 4 | CID000125337 | |
| Drug | MeOBGDTC | 2.60e-10 | 11 | 23 | 4 | CID000119173 | |
| Drug | alpha-mercapto-beta-(2-furyl)acrylic acid | 5.62e-10 | 13 | 23 | 4 | CID006437871 | |
| Drug | Cadmium-thionein | 7.87e-10 | 14 | 23 | 4 | CID000198548 | |
| Drug | diamsar | 7.87e-10 | 14 | 23 | 4 | CID000146286 | |
| Drug | MT45 | 1.07e-09 | 15 | 23 | 4 | CID000431865 | |
| Drug | urs-12-ene-3beta,28-diol | 1.07e-09 | 15 | 23 | 4 | CID000092802 | |
| Drug | ZnATP | 1.87e-09 | 17 | 23 | 4 | CID006455240 | |
| Drug | bismuth nitrate | 1.87e-09 | 17 | 23 | 4 | CID000107711 | |
| Drug | azelaic bishydroxamic acid | 1.87e-09 | 17 | 23 | 4 | CID000065268 | |
| Drug | AC1O3QMZ | 3.04e-09 | 19 | 23 | 4 | CID006334573 | |
| Drug | cadmium oxide | 4.68e-09 | 21 | 23 | 4 | CID000014782 | |
| Drug | 4-(2-pyridylazo)resorcinol | 4.68e-09 | 21 | 23 | 4 | CID000104300 | |
| Drug | 4-(2-pyridylazo)resorcinol | 5.72e-09 | 22 | 23 | 4 | CID005370169 | |
| Drug | zinc hydroxide | 5.72e-09 | 22 | 23 | 4 | CID000062742 | |
| Drug | iproplatin | 6.92e-09 | 23 | 23 | 4 | CID003034746 | |
| Drug | manganese sulfate monohydrate | 6.92e-09 | 23 | 23 | 4 | CID000166832 | |
| Drug | beta-damascenone | 8.29e-09 | 24 | 23 | 4 | ctd:C075388 | |
| Drug | hinokitiol | 9.87e-09 | 25 | 23 | 4 | CID000003611 | |
| Drug | BGDTC | 1.17e-08 | 26 | 23 | 4 | CID000105107 | |
| Drug | MT20 | 1.17e-08 | 26 | 23 | 4 | CID003025942 | |
| Drug | Oral-Turinabol | 1.37e-08 | 27 | 23 | 4 | CID000098521 | |
| Drug | Zinc chromate hydroxide | 1.85e-08 | 29 | 23 | 4 | CID000027567 | |
| Drug | Ormaplatino | 2.44e-08 | 31 | 23 | 4 | CID006434704 | |
| Drug | alpha-hederin | 2.79e-08 | 32 | 23 | 4 | CID000073296 | |
| Drug | Zinquin | 3.17e-08 | 33 | 23 | 4 | CID000132933 | |
| Drug | zinc acetate dihydrate | 3.17e-08 | 33 | 23 | 4 | CID000636168 | |
| Drug | rhodanine | 3.60e-08 | 34 | 23 | 4 | CID001201546 | |
| Drug | DEDTC | 3.60e-08 | 34 | 23 | 4 | CID000032064 | |
| Drug | p-hydroxyphenyllactic acid | 4.56e-08 | 36 | 23 | 4 | CID000009378 | |
| Drug | methylcyclopentadienyl)manganese tricarbonyl | 5.11e-08 | 37 | 23 | 4 | CID005150494 | |
| Drug | genistin | 5.71e-08 | 38 | 23 | 4 | CID005281377 | |
| Drug | cerium | 6.36e-08 | 39 | 23 | 4 | CID000008762 | |
| Drug | 6-aminonicotinamide | 6.36e-08 | 39 | 23 | 4 | CID000009500 | |
| Drug | 1q1g | 6.36e-08 | 39 | 23 | 4 | CID000447992 | |
| Drug | arsenic(III | 7.06e-08 | 40 | 23 | 4 | CID000104734 | |
| Drug | bismuth | 8.63e-08 | 42 | 23 | 4 | CID000105143 | |
| Drug | trans-DDP | 1.05e-07 | 44 | 23 | 4 | CID000084691 | |
| Drug | AC1L45V9 | 1.15e-07 | 45 | 23 | 4 | CID000151205 | |
| Drug | trien | 1.26e-07 | 46 | 23 | 4 | CID000005565 | |
| Drug | midodrine | 1.37e-07 | 47 | 23 | 4 | CID000004195 | |
| Drug | octachloronaphthalene | 1.37e-07 | 47 | 23 | 4 | CID000016692 | |
| Drug | neutral red | 1.37e-07 | 47 | 23 | 4 | CID000011105 | |
| Drug | dimercaprol | 1.49e-07 | 48 | 23 | 4 | CID000003080 | |
| Drug | DL-propargylglycine | 1.49e-07 | 48 | 23 | 4 | CID000095575 | |
| Drug | dimethylmercury | 2.07e-07 | 52 | 23 | 4 | CID000011645 | |
| Drug | oleanolic acid | 2.07e-07 | 52 | 23 | 4 | CID000010494 | |
| Drug | auranofin | 2.07e-07 | 52 | 23 | 4 | CID006918453 | |
| Drug | Ridauran | 2.61e-07 | 55 | 23 | 4 | CID006333887 | |
| Drug | CH3Hg | 3.72e-07 | 60 | 23 | 4 | CID000007905 | |
| Drug | Disperse Blue 7 | 3.97e-07 | 61 | 23 | 4 | CID000018514 | |
| Drug | tetrathiomolybdate | 3.97e-07 | 61 | 23 | 4 | CID005245480 | |
| Drug | ZnSO4.7H2O | 4.53e-07 | 63 | 23 | 4 | CID000062639 | |
| Drug | L-beta-aspartyl phosphate | 6.55e-07 | 69 | 23 | 4 | CID000000832 | |
| Drug | zinc sulfate | 6.55e-07 | 69 | 23 | 4 | CID000024424 | |
| Drug | fluoroacetic acid | 7.78e-07 | 72 | 23 | 4 | CID000005236 | |
| Drug | ursolic acid | 7.78e-07 | 72 | 23 | 4 | CID000064945 | |
| Drug | Fe-NTA | 8.22e-07 | 73 | 23 | 4 | CID000027880 | |
| Drug | AC1MTZN9 | 1.02e-06 | 77 | 23 | 4 | CID003658056 | |
| Drug | selenium | 1.19e-06 | 80 | 23 | 4 | CID006326970 | |
| Drug | cilostazol | 1.59e-06 | 86 | 23 | 4 | CID000002754 | |
| Drug | methyl red | 1.59e-06 | 86 | 23 | 4 | CID000010303 | |
| Drug | acetylbetulinic acid | 1.74e-06 | 88 | 23 | 4 | CID000289984 | |
| Drug | adenosine 3',5'-cyclic phosphate | 1.77e-06 | 907 | 23 | 8 | CID000000274 | |
| Drug | CuSO4 | 2.08e-06 | 92 | 23 | 4 | CID000024462 | |
| Drug | S-nitrosocysteine | 2.18e-06 | 93 | 23 | 4 | CID003359494 | |
| Drug | CdCl2 | 2.68e-06 | 98 | 23 | 4 | CID000024947 | |
| Drug | rutin | 2.68e-06 | 98 | 23 | 4 | CID005280805 | |
| Drug | TPEN | 2.91e-06 | 100 | 23 | 4 | CID000005519 | |
| Drug | diethyldithiocarbamate | 3.03e-06 | 101 | 23 | 4 | CID000008987 | |
| Drug | p-terphenyl | 3.27e-06 | 103 | 23 | 4 | CID000007115 | |
| Drug | fluconazole | 3.81e-06 | 107 | 23 | 4 | CID000003365 | |
| Drug | zinc superoxide | 3.95e-06 | 108 | 23 | 4 | CID000014809 | |
| Drug | thiobarbituric acid | 5.63e-06 | 118 | 23 | 4 | CID002723628 | |
| Drug | NiCl2 | 5.82e-06 | 119 | 23 | 4 | CID000024385 | |
| Drug | Cys-cys | 5.82e-06 | 119 | 23 | 4 | CID000152238 | |
| Drug | tris(1,10-phenanthroline)chromium(III) chloride | 5.85e-06 | 4 | 23 | 2 | ctd:C495433 | |
| Drug | azathioprine | 6.01e-06 | 120 | 23 | 4 | CID000002265 | |
| Drug | isopropanol | 6.42e-06 | 122 | 23 | 4 | CID000003776 | |
| Drug | teleocidin B | 6.63e-06 | 123 | 23 | 4 | CID000072425 | |
| Drug | AC1L1Z2L | 6.63e-06 | 123 | 23 | 4 | CID000012201 | |
| Drug | sulfur mustard | 8.26e-06 | 130 | 23 | 4 | CID000010461 | |
| Drug | homocysteine thiolactone | 8.51e-06 | 131 | 23 | 4 | CID000107712 | |
| Drug | chlorambucil | 9.04e-06 | 133 | 23 | 4 | CID000002708 | |
| Drug | arsenate | 9.59e-06 | 135 | 23 | 4 | CID000000233 | |
| Drug | bis(N,N-diethyldithiocarbamate)Cu (II) complex | 9.74e-06 | 5 | 23 | 2 | ctd:C067982 | |
| Drug | acrolein | 9.87e-06 | 136 | 23 | 4 | CID000007847 | |
| Drug | DL-penicillamine | 1.08e-05 | 139 | 23 | 4 | CID000004727 | |
| Drug | cisplatin | 1.08e-05 | 139 | 23 | 4 | CID000002767 | |
| Drug | ozone | 1.20e-05 | 143 | 23 | 4 | CID000024823 | |
| Drug | vanadium | 1.42e-05 | 149 | 23 | 4 | CID000023990 | |
| Drug | lead compounds | 1.45e-05 | 150 | 23 | 4 | CID000073212 | |
| Drug | 5,5'-dithiobis(2-nitrobenzoic acid | 1.74e-05 | 157 | 23 | 4 | CID000006254 | |
| Drug | dihydrochloride | 1.83e-05 | 159 | 23 | 4 | CID000070978 | |
| Drug | al-Badry | 2.11e-05 | 165 | 23 | 4 | CID000004545 | |
| Drug | XK234 | 2.22e-05 | 167 | 23 | 4 | CID000454923 | |
| Disease | retinitis pigmentosa (biomarker_via_orthology) | 6.90e-11 | 13 | 18 | 4 | DOID:10584 (biomarker_via_orthology) | |
| Disease | median neuropathy (biomarker_via_orthology) | 9.66e-11 | 14 | 18 | 4 | DOID:571 (biomarker_via_orthology) | |
| Disease | kidney failure (biomarker_via_orthology) | 3.73e-10 | 19 | 18 | 4 | DOID:1074 (biomarker_via_orthology) | |
| Disease | Alzheimer's disease (biomarker_via_orthology) | 4.03e-08 | 58 | 18 | 4 | DOID:10652 (biomarker_via_orthology) | |
| Disease | atopic eczema | 3.42e-07 | 252 | 18 | 5 | EFO_0000274 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.23e-06 | 157 | 18 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | vitamin D measurement | 4.45e-05 | 336 | 18 | 4 | EFO_0004631 | |
| Disease | IGF-1 measurement | 3.05e-03 | 488 | 18 | 3 | EFO_0004627 | |
| Disease | sexual dimorphism measurement | 3.94e-03 | 1106 | 18 | 4 | EFO_0021796 | |
| Disease | atopic asthma | 6.45e-03 | 199 | 18 | 2 | EFO_0010638 | |
| Disease | asthma | 1.01e-02 | 751 | 18 | 3 | MONDO_0004979 | |
| Disease | psoriasis | 1.18e-02 | 273 | 18 | 2 | EFO_0000676 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CCGDSGCCGSSSTSC | 46 | Q9UGL9 | |
| CSAASSASGGSSCCA | 301 | A6QL63 | |
| SCTTGVSCACTGSCT | 6 | Q8N339 | |
| CCSSSGCGSFCCQSS | 91 | Q6L8G4 | |
| FPSCSTSGTCGSSCC | 11 | Q07627 | |
| YPSCSTSGTCGSSCC | 11 | Q8IUG1 | |
| STSGTCSSSCCQPSC | 51 | Q8IUG1 | |
| MASCSTSGTCGSSCC | 1 | P0C5Y4 | |
| STSGTCSSSCCQPSC | 51 | Q9BYS1 | |
| SCATGGSCTCAGSCK | 6 | P04732 | |
| SSCCSVSSGGCCGSS | 41 | Q5T7P2 | |
| SSSGCGSSCCQSSCC | 226 | Q6L8H1 | |
| SSCCSVSSGGCCGSS | 41 | Q5T7P3 | |
| SSCCSVSSGGCCGSS | 41 | Q5T751 | |
| VSSCCSVSSGGCCGS | 36 | Q5T752 | |
| SSCCSVSSGGCCGSS | 41 | Q5T753 | |
| SSCCSVSSGGCCGSS | 41 | Q5T754 | |
| CSSSGRGSSCCQSSC | 116 | P26371 | |
| SSSGCGSSCCQSSCC | 136 | P26371 | |
| CLSSCCGQTSCGSSC | 71 | Q9BYP9 | |
| SCATGGSCTCTGSCK | 6 | P04731 | |
| SCTTGGSCACAGSCK | 6 | P07438 | |
| MDLSCSCATGGSCTC | 1 | A1L3X4 | |
| SCATGGSCTCASSCK | 6 | A1L3X4 | |
| SCATGGSCSCASSCK | 6 | Q93083 | |
| IVCTSCGCSGSCGSS | 786 | Q8WYQ9 | |
| TLSSGSCPAMCTCSN | 276 | O75093 |